Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

TMCI Treace Medical Concepts, Inc. Common Stock
$4.50 -2.81% -0.13
Notify me if price changes either direction
Interactive Brokers Logotype

Buy TMCI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 301.1M
Enterprise value 320.7M
Trailing PE -4.8387096774194
Forward PE -5.3058825
PEG Ratio 0.33870967741935
Enterprise to EBITDA -6.92
Enterprise to revenue 1.562
Price to book MRQ 4.328215
Price to sales TTM 1.4286208

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 205.3M
EBITDA -46350000
Diluted EPS TTM -0.92
Total Cash (MRQ) 45.6M
Current ratio (MRQ) 2.903
Operating Cash Flow (TTM) -14576000

TMCI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent TMCI News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.